glp-1 bone loss Type 2 diabetes: Semaglutide may help protect health Positive impact of GIP, GLP-1

Blissenbach Board Certified Excellence Dr

Like any medication, GLP-1s can cause side effects, especially in the early stages of treatment

GLP-1R is expressed by various populations of central neurons, but it is still not fully clear which specific populations mediate the effects of GLP-1RAs

MedicalDaily Evidence Check Study type: Phase 3 randomized controlled trial (ATTAIN program) Participants: Adults with obesity or overweight with at least one weight-related comorbidity Approval date: April 1, 2026 What it found: Average weight loss of approximately 12.4% (about 27 lbs) at highest dose over 72 weeks What it did not prove: That it matches injectable GLP-1 efficacy

Make sure to follow the syringe's unit markings and your specific instructions

That escalation timeline is the same regardless of your starting BMI, though appetite suppression onset may vary based on individual factors